10
Jan
2016
Illumina, Arch, Bezos, Gates Bet $100M on Deep Sequencing for Early Cancer Detection
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account. 
Share:
8
Jan
2016
All the Biotech Deals and Financings You Can Grok Before JP Morgan 2016
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
21
Dec
2015
Which Biotechnologies Were Hyped, and Which Weren’t, in 2015
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
10
Nov
2015
Pursuing a Hard Cancer Target: Q&A With Warp Drive CEO Laurence Reid
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
2
Oct
2015
Fallout from the Drug Pricing Fiasco, the New Thing in Genome Editing & More
This content is available for subscribers of the Timmerman Report. Subscribe Now
Share:
1
Oct
2015
The Next Macro (Phage) Thing in Immuno-Oncology
This content is available for subscribers of the Timmerman Report. Subscribe Now
Share:
11
Sep
2015
Post-Labor Day Hangovers, Ipi-Nivo Combo Data & the PCSK9 Pricing Debate
This content is available for subscribers of the Timmerman Report. Subscribe Now
Share:
19
Aug
2015
Not Just Research, Not Just Diagnostics: Adaptive Veers into T-Cell Drug Discovery
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.[/memberful_sign_in_link]
Share:
21
Jul
2015
The Non-Compete Chill Has Passed: Bristol-Myers, MedImmune Settle Over I-O Star
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
17
Jul
2015
Forget Price Controls – Value-Based Pricing is the New Threat to Drug Development
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
15
Jun
2015
It’s Time to Re-Think Some Assumptions About Cancer R&D
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
11
Jun
2015
NEA, Polaris Bet $22M on Startup, Xtuit, to Break Down Tumor Microenvironment
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
29
May
2015
Cancer Immunotherapy’s Amazing Four-Year Run: A Timeline of Events
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
22
May
2015
The Genentech Alumni: Where Are They Now?
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
16
Apr
2015
AACR Conference Preview: Five Themes To Watch In Immunotherapy
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
6
Apr
2015
Baseball Meets Biotech, Where Hope Springs Eternal
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
4
Apr
2015
Will We Just Give Up on Federal Funding for Research? I Sure Hope Not
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
30
Mar
2015
Cancer Combos Are the Way Forward. Will Drugmakers Put Patients First?
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
25
Feb
2015
The Tularik Alumni: Where Are They Now?
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
20
Feb
2015
Five Things to Watch at Next Week’s Big Genomics Show
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
